Moleculin Biotech, Inc. MBRX
8.59 USD +0.29 (+3.49%)
Nov 4, 2026, 11:28 AM EST
8.13 Day range 8.65
3.22 52-week range 253.00
- YTD
- +159.52%
- 1 year
- -30.89%
Analyst view
Price target (mean) 18.00 +109.5% upside
Now 8.59
- Target (low)
- 8.00
- Target (mean)
- 18.00
- Target (high)
- 28.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -14.09 | -14.09 – -14.09 | -14.28 | +1.3% | 0 | 0.0% | 1 |
| Next year | -5.28 | -5.28 – -5.28 | -14.09 | +62.5% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 12, 2024 | Maxim Group | Maintained | Buy | Buy |
| Apr 12, 2024 | Roth MKM | Maintained | Buy | Buy |
| Mar 26, 2024 | Maxim Group | Maintained | Buy | Buy |
| Dec 14, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 18, 2023 | Roth MKM | Maintained | — | Buy |
| Mar 24, 2023 | Oppenheimer | Reiterated | — | Outperform |